A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

January 4, 2022

Study Completion Date

January 4, 2022

Conditions
Respiratory Syncytial Virus
Interventions
DRUG

EDP-938

Four tablets daily for 5 days

DRUG

Placebo

Four tablets daily for 5 days

Trial Locations (29)

1431

Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia

1510

Medical Center Hera, Sofia

2700

Multiprofile Hospital for Active Treatment Puls, Blagoevgrad

3010

Lakeland Clinical Trials, Rotorua

3035

City Outpatient Clinic #9, Kyiv

Medical Center of LLC Preventclinic, Kyiv

3200

Lakeland Clinical Trials - Waikato, Hamilton

3320

Medical Center Zdrave-1 OOD, Kozloduy

4050

Limited Liability Company Medical Center Consilium Medical, Kyiv

5000

Medical Center Tara OOD, Veliko Tarnovo

6300

Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases - Haskovo EOOD, Haskovo

6850

Clinical Projects Research SA pty Ltd, Worcester

27103

Progressive Medicine of the Triad, LLC, Winston-Salem

28150

Carolina Research Center, Shelby

28401

PMG Research of Wilmington, Wilmington

33155

Miami Clinical Research - ClinEdge - PPDS, Miami

35124

Cahaba Research Inc. - Birmingham, Pelham

35209

Central Alabama Research, Birmingham

36039

Municipal Enterprise The 1st City Clinical Hospital of Poltava City Council, Poltava

68005

Pioneer Clinical Research LLC, Bellevue

68701

Meridian Clinical Research, Norfolk

76014

Communal Non-Profit Enterprise City Clinical Hospital #1 of Ivano-Frankivsk City Council, Ivano-Frankivsk

76550

FMC Science, Lampasas

89121

Clinical Research of South Nevada, Las Vegas

90717

Torrance Clinical Research Institute, Lomita

92804

Saint Joseph's Clinical Research, Anaheim

B1900AVG

Instituto Medico Platense, Buenos Aires

33-100

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z.o.o, Tarnów

14-100

Specjalistyczny Osrodek Leczniczo-Badawczy Zbigniew Zegota, Ostróda

Sponsors
All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

Enanta Pharmaceuticals, Inc

INDUSTRY